0.41p-0.02 (-4.65%)28 Mar 2024, 12:23
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Oxford Cannabinoid Technologies Holdings PLC Fundamentals

Company NameOxford Cannabinoid Technologies Holdings PLCLast Updated2024-03-28
IndustryBiotechnologySectorHealthcare
Shares in Issue1.088 bnMarket Cap£4.46 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.01EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.4308Cash Equity Ratio0.5815
Quick Ratio3.3214Current Ratio3.32
Price To Book Value2.4004ROCE0

Oxford Cannabinoid Technologies Holdings PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Oxford Cannabinoid Technologies Holdings PLC Company Financials

Assets202320222021
Tangible Assets00£57,391.00
Intangible Assets£7,272.00£46,080.00£101,657.00
Investments000
Total Fixed Assets£7,272.00£46,080.00£159,048.00
Stocks000
Debtors£301,151.00£1.51 m£92,321.00
Cash & Equivalents£2.30 m£9.17 m£14.63 m
Other Assets000
Total Assets£4.50 m£11.82 m£15.21 m
Liabilities202320222021
Creditors within 1 year£583,920.00£2.03 m£951,135.00
Creditors after 1 year00£46,864.00
Other Liabilities000
Total Liabilities£583,920.00£2.03 m£997,999.00
Net assets£3.91 m£9.79 m£14.21 m
Equity202320222021
Called up share capital£9.60 m£9.60 m£9.60 m
Share Premium£11.88 m£11.88 m£11.88 m
Profit / Loss-£7.03 m-£5.50 m-£3.37 m
Other Equity£3.91 m£9.79 m£14.21 m
Preference & Minorities000
Total Capital Employed£3.91 m£9.79 m£14.21 m
Ratios202320222021
Debt Ratio0£0.000
Debt-to-Equity0£0.000
Assets / Equity1.43081.43081.4308
Cash / Equity0.58150.58150.5815
EPS-£0.01£-0.00£-0.00
Cash Flow202320222021
Cash from operating activities-£6.87 m-£5.37 m-£1.78 m
Cashflow before financing-£6.87 m-£5.47 m£14.27 m
Increase in Cash-£6.87 m-£5.47 m£14.32 m
Income202320222021
Turnover000
Cost of sales£4.30 m£2.89 m£445,400.00
Gross Profit-£4.30 m-£2.89 m-£445,400.00
Operating Profit-£7.04 m-£5.50 m-£3.35 m
Pre-Tax profit-£7.03 m-£5.50 m-£3.37 m

Oxford Cannabinoid Technologies Holdings PLC Company Background

SectorHealthcare
ActivitiesOxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.
Latest Interim Date30 Jan 2024
Latest Fiscal Year End Date31 Aug 2023

Oxford Cannabinoid Technologies Holdings PLC Directors

AppointedNamePosition
2024-02-26Ms. Julie Patricia PomeroyNon-Executive Director,Chairman
2023-10-20Mr. Indraneil MahapatraNon-Executive Director
2024-02-26Ms. Clarissa Ann Sowemimo-CokerExecutive Director,Chief Executive Officer
2023-09-06Ms. Karen LoweExecutive Director,Finance Director
2023-01-24Mr. Gavin Hilary SathianathanNon-Executive Director
2023-09-06Mr. Bishrut MukherjeeNon-Executive Director
2022-08-04Mr. Charanjit Cheryl DhillonNon-Executive Director

Oxford Cannabinoid Technologies Holdings PLC Contact Details

Company NameOxford Cannabinoid Technologies Holdings PLC
Address1 Maddox Street, Maddox House, London, W1S 2PZ
Telephone+44 2030342820
Websitehttps://www.oxcantech.com

Oxford Cannabinoid Technologies Holdings PLC Advisors